ردیف

عنوان مقاله

نویسنده

عنوان همایش

1

MOBILE TEAMS BLOOD COLLECTION AND THEIR ROLE IN PROVIDING AHWAZ BLOOD SUPPLY DURING 2008UNTIL 2010.

jalalifar MA,saki N,….

VOX Sanguinis . V 101.SUPPLEMENT 1 JULLY 2011.(poster)

2

Abstract 3539: Can Stop Trial Velocity Criteria Be Applied To Iranian Children With Sickle Cell Disease?

Reza B Shahripour1; Bijan Keikhaei2; Mahmoodreza Azarpakhooh3; Seyed A Sajedi3; Moteza Oghbaee3; Asad A Chaudhary1; Stanislava Kolieskova1; Jessica Kepplinger1; Kristian Barlinn1; Karen C Albright4; Andrei V Alexandrov1.

International Stroke Conference Poster Abstracts.

3

EFFICACY OF SERUM TRANSFERRIN RECEPTOR IN DIFFERENTIATING IRON DEFICIENCYANEMIA FROM ß–THALASSEMIA TRAIT

Bijan Keikhaei, Ali Reza Mohseni.

12th International Conference on Thalassaemia and Other Haemoglobinopathies,14th TIF Conference for Patients and ParentsMay 11 - 14, 2011.

4

HEMOGLOBIN D IS THE SECOND MOSTCOMMON HB VARIANT IN PRE-MARITALGENETIC COUNSELING IN SOUTH WEST IRAN.

Bijan Keikhaei.

12th International Conference on Thalassaemia and Other Haemoglobinopathies,14th TIF Conference for Patients and ParentsMay 11 - 14, 2011.

5

HIGH ALTITUDE SPLENIC INFARCTION INSICKLE CELL TRAIT.

Bijan Keikhaei.

12th International Conference on Thalassaemia and Other Haemoglobinopathies,14th TIF Conference for Patients and ParentsMay 11 - 14, 2011.

6

EFFICACY AND SAFETY OF OSVERAL®. ANEW BRAND OF DEFERASIROX. IN IRANIAN MAJOR THALASSEMIC PATIENTS WITH TRASFUSIONAL IRON OVERLOAD: AONE YEAR PROSPECTIVE MULTICENTRIC OPEN-LABEL NON-COMPARATIVE STUDY.

Bijan Keikhaei9.

12th International Conference on Thalassaemia and Other Haemoglobinopathies,14th TIF Conference for Patients and ParentsMay 11 - 14, 2011.

7

EFFICACY AND SAFETY OF OSVERAL®. ANEW BRAND OF DEFERASIROX. IN IRANIAN MAJOR THALASSEMIC PATIENTS WITH TRASFUSIONAL IRON OVERLOAD: AONE YEAR PROSPECTIVE MULTICENTRIC OPEN-LABEL NON-COMPARATIVE STUDY.

Bijan Keikhaei9.

12th International Conference on Thalassaemia and Other Haemoglobinopathies,14th TIF Conference for Patients and ParentsMay 11 - 14, 2011.

8

THE EFFECTIVENESS OF GENETIC COUNSELTING IN REDUCING INCIDENCE RATE OF THALASSEMIA MAJOR AND SICKLE CELL DISEASE IN KHUZESTAN PROVINCE.

Bijan Keikhaei,…

12th International Conference on Thalassaemia and Other Haemoglobinopathies,14th TIF Conference for Patients and ParentsMay 11 - 14, 2011.

9

EFFICACY AND  SAFETY OF OSVERAL® - A NEW BRAND OF DEFERASIROX - IN IRANIAN MAJOR THALASSEMIC PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD: A ONE YEAR PROSPECTIVE MULTICENTRIC OPEN-LABEL NON-COMPARATIVE STUDY.

Peyman Eshghi1, Zahra Farahmandinia2, Mohammad Ali,Moulavi3, Majid Naderi4, Maryam Jafroodi5, Hamid Hoorfar6, Kambiz Davari7, Azita Azarkeivan8, Bijan Keikhaie9, Shahla Ansari10, Majid Arasteh11

12th International Conference on Thalassaemia and Other Haemoglobinopathies, 14th TIF Conference for Patients and Parents. ANTALIA-TURKEY May 11 - 14, 2011.

10

EFFICACY OF SERUM TRANSFERRIN RECEPTOR IN DIFFERENTIATING IRON DEFICIENCY ANEMIA FROM ß–THALASSEMIA TRAIT.

Bijan Keikhaei, Ali Reza Mohseni

12th International Conference on Thalassaemia and Other Haemoglobinopathies, 14th TIF Conference for Patients and Parents. ANTALIA-TURKEY May 11 - 14, 2011.

11

THE EFFECTIVENESS OF GENETIC COUNSELING IN REDUCING INCIDENCE RATE OF THALASSEMIA MAJOR AND SICKLE CELL DISEASE IN KHUZESTAN PROVINCE.

Bijan Keikhaei, Sh Jousheghani.

12th International Conference on Thalassaemia and Other Haemoglobinopathies, 14th TIF Conference for Patients and Parents. ANTALIA-TURKEY May 11 - 14, 2011.